M Buclon

706 total citations
17 papers, 553 citations indexed

About

M Buclon is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, M Buclon has authored 17 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in M Buclon's work include Renal cell carcinoma treatment (3 papers), Amino Acid Enzymes and Metabolism (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). M Buclon is often cited by papers focused on Renal cell carcinoma treatment (3 papers), Amino Acid Enzymes and Metabolism (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). M Buclon collaborates with scholars based in France, Switzerland and Morocco. M Buclon's co-authors include Christine Lasset, Christine Chevreau, David Pérol, Alain Ravaud, Sylvie Négrier, Bernard Escudier, Jean‐Yves Douillard, F. Gómez, J. W. L. Robinson and Éric Bouffet and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

M Buclon

17 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Buclon France	11	284	258	183	147	99	17	553
Raffaele Cozza Italy	15	154 0.5×	215 0.8×	115 0.6×	106 0.7×	110 1.1×	38	551
Kara Penne United States	7	203 0.7×	260 1.0×	256 1.4×	154 1.0×	63 0.6×	11	691
David N. Shapiro United States	8	315 1.1×	367 1.4×	133 0.7×	74 0.5×	38 0.4×	9	655
Qun-Li Shi China	18	265 0.9×	273 1.1×	207 1.1×	122 0.8×	87 0.9×	41	584
Nilüfer Güler Türkiye	12	121 0.4×	223 0.9×	249 1.4×	137 0.9×	63 0.6×	49	641
Stacy Mosier United States	9	360 1.3×	275 1.1×	196 1.1×	258 1.8×	46 0.5×	9	747
Ana Herrero Spain	14	125 0.4×	112 0.4×	217 1.2×	137 0.9×	86 0.9×	41	591
Holly Stevenson United States	15	94 0.3×	404 1.6×	119 0.7×	187 1.3×	86 0.9×	19	638
Catalina Vadell Spain	10	591 2.1×	193 0.7×	624 3.4×	71 0.5×	75 0.8×	27	1.0k
Susan Hunter United States	12	187 0.7×	58 0.2×	406 2.2×	148 1.0×	82 0.8×	16	662

Countries citing papers authored by M Buclon

Since Specialization

Citations

This map shows the geographic impact of M Buclon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Buclon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Buclon more than expected).

Fields of papers citing papers by M Buclon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Buclon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Buclon. The network helps show where M Buclon may publish in the future.

Co-authorship network of co-authors of M Buclon

This figure shows the co-authorship network connecting the top 25 collaborators of M Buclon. A scholar is included among the top collaborators of M Buclon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Buclon. M Buclon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Négrier, Sylvie, et al.. (2007). Annonce du projet thérapeutique en cancérologie. Facteurs influençant la réussite de l'entretien patient-médecin et intérêt d'un deuxième entretien non médical. La Presse Médicale. 36(5). 779–785. 3 indexed citations

Négrier, Sylvie, Frédéríc Gomez, Alain Ravaud, et al.. (2005). Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie. World Journal of Urology. 23(3). 161–165. 39 indexed citations

Marec‐Bérard, Perrine, et al.. (2003). Risk Model Predictive of Severe Anemia Requiring RBC Transfusion After Chemotherapy in Pediatric Solid Tumor Patients. Journal of Clinical Oncology. 21(22). 4235–4238. 14 indexed citations

Négrier, Sylvie, Bernard Escudier, F. Gómez, et al.. (2002). Prognostic factors of survival and rapid progression in782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie. Annals of Oncology. 13(9). 1460–1468. 273 indexed citations

Ledermann, Jonathan A., R. M. Herd, D Maraninchi, et al.. (2001). High-dose chemotherapy for ovarian carcinoma: Long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT). Annals of Oncology. 12(5). 693–699. 21 indexed citations

Bergeron, Christophe, Cezar Iliescu, Philippe Thiesse, et al.. (2001). Does nephroblastomatosis influence the natural history and relapse rate in Wilms' tumour? A single centre experience over 11 years. European Journal of Cancer. 37(3). 385–391. 16 indexed citations

Melhaoui, Ahmed, et al.. (2000). Cytotoxic effect and electrophysiological activity of (S)-bgugaine, an alkylpyrrolidine alkaloid against MRC-5 fibroblasts. Phytomedicine. 7(2). 145–149. 3 indexed citations

Frappaz, Didier, Jean Michon, Carole Coze, et al.. (2000). LMCE3 Treatment Strategy: Results in 99 Consecutively Diagnosed Stage 4 Neuroblastomas in Children Older Than 1 Year at Diagnosis. Journal of Clinical Oncology. 18(3). 468–468. 62 indexed citations

Bouffet, Éric, François Doz, M.C. Demaille, et al.. (1998). Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?. British Journal of Cancer. 77(8). 1321–1326. 59 indexed citations

10.

Frappaz, Didier, M Brunat-Mentigny, M Buclon, et al.. (1997). Initial Management of Advanced Burkitt Lymphoma in Children: Is There Still a Place for Surgery?. Pediatric Hematology and Oncology. 14(6). 555–561. 15 indexed citations

11.

Cartier, Marie, M Buclon, & J. W. L. Robinson. (1979). Preliminary studies on the characteristics of phenylalanine and β-methyl-glucoside transport in the tench intestine in vitro. Comparative Biochemistry and Physiology Part A Physiology. 62(2). 363–370. 15 indexed citations

12.

Sepúlveda, Francisco V., M Buclon, & J. W. L. Robinson. (1977). [Harmaline, an inhibitor of the process of intestinal transport associated sodium-ion transport].. PubMed. 1(1). 87–93. 10 indexed citations

13.

Buclon, M, et al.. (1977). The reversibility of the inhibition of intestinal amino-acid transport by harmaline. Naunyn-Schmiedeberg s Archives of Pharmacology. 298(1). 57–59. 2 indexed citations

14.

Buclon, M, et al.. (1976). Differential effects of harmaline and ouabain on intestinal sodium, phenylalanine and ?-methyl-glucoside transport. Naunyn-Schmiedeberg s Archives of Pharmacology. 295(3). 231–236. 12 indexed citations

15.

Buclon, M, et al.. (1975). [Permeability of sublingual mucosa to organic molecules. Limited role of sublingual absorption in aerosol vaccinations].. PubMed. 169(5). 1227–31. 1 indexed citations

16.

Buclon, M. (1974). Bioelectric potentials and the transfer of amino acids across the digestive epithelium of the tench (Tinca tinca L.).. PubMed. 68(2). 157–80. 7 indexed citations

17.

Cartier, M S & M Buclon. (1973). [Comparative ultrastructure of the brush border of the enterocyte, depending upon the nutritional state in 3 cyprinides: the tench (Tinca tinca L.), the carp(Cyprinus carpio L.) and the goldfish(Carassius auratus L.)].. PubMed. 27(4). 181–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact